09/11/2024  13:03:53 Diferencia -0.30 Volumen Bid13:03:53 Ask13:03:53 Capitalización de mecado Dividendo A. P/E Ratio
402.50EUR -0.07% -
Volumen de negocios: -
402.50Volumen de oferta: - 405.30Tamaño/ Volumen/ Formato de Ask: - 33.1 mil millonesEUR - -

Descripción de negocio

IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs more than 7,000 people and offers products to customers in more than 175 countries.
 

Consejo de gestión & Consejo de supervisión

CEO
Jay Mazelsky
Consejo de gestión
Brian P. McKeon, Irene Chang Britt, Michael Lane, James F. Polewaczyk, Martin Smith, Sharon E. Underberg, Michael P. Johnson, Kerry Bennett, Mike Erickson, George J. Fennell, Ken Grady, John Hart, Dan Janson, Michael Schreck, Murthy Yerramilli
Consejo de supervisión
Lawrence D. Kingsley, Bruce L. Claflin, Daniel M. Junius, Dr. Asha S. Collins, Dr. Sophie V. Vandebroek, Dr. Stuart M. Essig, Jay Mazelsky, Jonathan W. Ayers, M. Anne Szostak, Sam Samad, Irene Chang Britt
 

Datos de la empresa

Nombre: IDEXX Laboratories Inc.
Dirección: One IDEXX Drive,Westbrook, Maine 04092, USA
Teléfono: +1-207-556-0300
Fax: +1-207-556-4346
E-mail: -
Internet: www.idexx.com
Industria: Biotechnology
Sector: Biotechnology
Subsector: Biotechnology
Fin del año financiero: 31/12
Acciones de libre circulación: 57.24%
Fecha de OPI: 21/06/1991

Relación con inversores

Nombre: John Ravis
IR teléfono: +1-207-556-8155
IR-fax: +1-207-556-4427
IR e-mail: investorrelations@idexx.com

Accionistas mayoritarios

Otros
 
57.36%
BlackRock Inc.
 
10.96%
Vanguard Group
 
10.14%
State Street Corporation
 
4.57%
ALLIANCEBERNSTEIN L P
 
3.56%
Fundsmith LLP
 
3.30%
BAMCO INC NY
 
2.79%
GEODE CAPITAL MANAGEMENT LLC
 
2.55%
Franklin Resources Inc.
 
1.70%
Otros
 
3.06%